Global Biochips Market was worth $7.15 billion in 2016 and estimated to be growing at a CAGR of 21.80%, to reach $19.17 billion by 2021

07/giu/2017 15:01:44 Market Data Forecast Contatta l'autore

Questo comunicato è stato pubblicato più di 1 anno fa. Le informazioni su questa pagina potrebbero non essere attendibili.

The Global Biochips Market was worth $ 7.15 billion in 2016 and estimated to be growing at a CAGR of 21.80%, to reach $ 19.17 billion by 2021. A biochip is an assembly of miniaturized sites That are organized tests on a compact substrate, Which Allows many tests to be executed at the same time to reach higher throughput and speed.


Usually, the surface area of a biochip is no bigger than a fingernail. Like a computer chip can accomplish That millions of mathematical tasks in one second, a biochip can implement Thousands of biological responses, such as decoding genes, in the duration of a few seconds.


Full report at:


The growth of the Global Biochips Market is Mainly driven by factors such as an Increased application in cancer study, the surge in the utilization of personalized medicine, and Increased commercial uses of biochips. However, factors such as an availability of substitute technologies, low commercial suitability two to higher costs, and standardization concerns are restraining the growth of the market.


The Global Biochips market is segmented based on Type, End User, and Fabrication Technology. The market for Biochips, on the basis of Type is segmented into DNA Chips, Lab-On-A-Chip, and Protein Chips. Further DNA Chips are segmented into SNP Genotyping, Genomics, Agricultural Biotechnology, Gene Expression, Cancer Diagnosis & Treatment, Drug Discovery, and Others. Lab-On-A-Chips are segmented into Further Clinical Diagnostics IVD & POC, Drug Discovery, Genomics, and Proteomics. Further Protein Chips are segmented into Expression Profiling, High-Throughput Screening, Proteomics, Diagnostics and Drug Discovery. On the basis of type, DNA Chips are the largest segment, Followed by lab-on-chips and protein biochips market, two to development in the proteomics and genomics field. However, enhancement in the field of recombinant proteins would assist the growth of protein biochips market. On the basis of End User, the global Biochips market is segmented into Hospitals and Diagnostics Centers, Biotechnology and Pharmaceutical Companies, Academic & Research Institutes. The Center Hospitals and Diagnostics segment dominates the market, as it is primarily driven by various factors such as Increasing government funding and technological advancements.


Request sample:


The market has Also Been geographically segmented into North America, Europe, Asia-Pacific, Latin America and Middle-East & Africa. North America is leading the global Biochips market two to technological advancements and a large pool of aging populace. However, Asia-Pacific is developing as one of the fastest growing market two to easy access to latest technologies, and promising government schemes.


The recent developments in the global biochips market includes the outsourcing of biochips technology, Which would aid in decreasing labor cost and capital prerequisites. The major companies dominating the global market Biochips are Agilent Technologies Inc., Fluidigm Corporation, PerkinElmer Inc., Bio-Rad Laboratories Inc., GE Healthcare, Cepheid Inc., Illumina Inc., and Thermo Fisher Scientific Inc.


Request Discount:


About Market Data Forecast:

The publisher of this report is Market Forecast Data Whose strong lies in Market Research and Business Intelligence. Handling Both individual and corporate clients across multiple business domains they offer syndicated / research customized to suit the client's research objective. Their research reports section offers a wide variety of market studies ranging from all-encompassing comprehensive market studies to product specific niche markets covering North America among other regions of the global market as well. For more info kindly visit,



Abhishek Shukla

Sales Manager (International Business Development)

Market Data Forecast

Direct Line: + 1-888-702-9626

Mobile: +91 998 555 0206


Visit MarketDataForecast Blog @


View Latest Press Releases of MDF @

blog comments powered by Disqus è un servizio offerto da Factotum Srl